# Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea

Source: https://onco.cc/key-papers/paper-nguyen-hpv-screen-treat-png-bmjgh-2022/  
OnCo record `paper-nguyen-hpv-screen-treat-png-bmjgh-2022` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A model calibrated to Papua New Guinea found self-collected HPV screen-and-treat more effective and more cost-effective than visual inspection with acetic acid, and estimated it could prevent 23,000 to 29,000 deaths over 50 years if scaled to 70% coverage from 2023.

## Summary

The authors note that Papua New Guinea has a high burden of cervical cancer but no national cervical screening programme. They calibrated the Policy1-Cervix model to the country, compared 38 strategies of self-collected HPV screen-and-treat and visual inspection with acetic acid (VIA), and estimated effectiveness, cost-effectiveness and budget impact, assuming HPV testing cost US$18.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: BMJ Global Health
- Year: 2022
- DOI: 10.1136/bmjgh-2021-007380
- Authors: Nguyen DTN, Simms KT, Keane A, et al.
- Findings: Self-collected HPV screen-and-treat was more effective and more cost-effective than VIA; VIA screening was not effective or cost-effective.; Twice or three times lifetime screening was cost-effective at half of GDP per capita, with an incremental cost-effectiveness ratio of US$460 to US$656 per life-year saved.; If scale-up reached 70% coverage from 2023, it could prevent 33,000 to 42,000 cases and 23,000 to 29,000 deaths over the next 50 years.
- What it means: It gives Papua New Guinea its own estimate of what a national HPV screen-and-treat programme could achieve and what it would cost.
- Caveats: A model: its outputs depend on assumed test performance, costs and coverage.

## Sources

- DOI: https://doi.org/10.1136/bmjgh-2021-007380
- PubMed: https://pubmed.ncbi.nlm.nih.gov/35241461/

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- technologies: [HPV DNA testing and self-sampling](https://onco.cc/technologies/hpv-testing/)
- institutions: [National Department of Health, Papua New Guinea](https://onco.cc/institutions/png-national-department-of-health/)

---
JSON: https://onco.cc/api/v1/entities/paper-nguyen-hpv-screen-treat-png-bmjgh-2022.json